Incannex Receives Ethics Approval to Commence Phase 1 Clinical Trial of Multi-Use Anti-Inflammatory Drug IHL-675A Jul 21, 2022 | ASX News, Incannex Healthcare (ASX:IHL)
Nyrada Inc: Change of Registered Office and Principal Place of Business Apr 26, 2021 | ASX News, Nyrada Inc (ASX:NYR)